Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen

Abstract

Initiation of treatment at a stage of preserved immunity is associated with a more durable virological response under protease inhibitor. Every effort should be made to monitor and strengthen adherence to therapy, even in patients having early virological response.